


Experience the eye-opening possibilities with Upneeq! If your eyes look “tired” or “sleepy,” you may have a condition called acquired blepharoptosis (also known as acquired ptosis or low-lying lids). Upneeq is the only FDA-approved prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.
Most patients in clinical trials had a lift in their eyelids in as little as 2 hours. 84% of patients had some level of improvement; 74% of patients had more than 50% improvement.
Upneeq also has helped patients with acquired ptosis see more – on the first day of treatment! 87.8% of patients had some level of improvement; 40.8% of patients had at least 50% improvement on Day 14 (2 hours after applying Upneeq).
IMPORTANT SAFETY INFORMATION
UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.
The most common adverse reactions with UPNEEQ (occurring in 1-5% of patients) were eye inflammation, eye redness, dry eye, blurred vision, eye pain at time of use, eye irritation, and headache.
These are not all of the possible side effects of UPNEEQ. Tell your doctor if you have any side effect that bothers you or does not go away. Call your doctor for medical advice about side effects.